Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

• Status: Completed
• Trial end date: 2013-05-01

Summary

This study will evaluate the safety and efficacy of AGN-214868 in patients with idiopathic overactive bladder (IOAB) and urinary incontinence.

• Phase: Phase 2

Details

• Lead Sponsor: Allergan